I recently attended the AVA conference and a lot of reference was made to future quidelines coming around tracking and monitoring of BSI's from PIV's. Our hospital is looking at implementing some improvements around decreasing this risk. Lynn do you know what the recommendations might be when the INS 2021 guidelines are released? And do you know of any publications that speak to this problem. The three of us that attended the conference are looking at making a presentation to the rest of our team and managers to start the process. But, we know their first question will be what is the evidence and how do we know this will become a guideline.